NHI on NYSE
NATIONAL HEALTH INVESTORS INC
American real estate investment trust based in Baltimore, active since 19912
In its 2026 annual report the company says: “We own, lease, operate and finance the development of high-quality real estate properties, focusing on senior housing communities and medical facilities. We operate through two reportable segments, Real Estate Investments and Senior Housing Operating Portfolio.”5 Its shares trade on NYSE under the symbol NHI.2
Price unavailable
Last updated Oct 21, 2026.
Overview
Compare with ACRES Commercial Realty Corp., ONE LIBERTY PROPERTIES INC or NEXPOINT DIVERSIFIED REAL ESTATE TRUST, or pick any stock.
- TickerNHI on NYSE2
- IndustryReal Estate Investment Trusts2
- HeadquartersBaltimore, United States2
- Incorporated inMD3
- Business address222 Robert Rose Drive, Murfreesboro, Tn 371293
- Filer categoryLarge accelerated filer3
- Legal formStock Corporation2
- LEI549300ZPKZIG6DKDEC022
- StatusActive2
- LEI statusIssued and current2
- Registered addressC/O NATIONAL REGISTERED AGENTS, INC. OF MD, 21093-2264 Lutherville Timonium, United States2
- Registered withBusiness Services (Maryland Department of Assessments and Taxation), D032584802
See how the biggest companies compare on our leaderboards
National Health Investors, Inc. (“NHI”, the “Company”, “we”, “us” or “our”), established in 1991 as a Maryland corporation, is a self-managed real estate investment trust (“REIT”). We own, lease, operate and finance the development of high-quality real estate properties, focusing on senior housing communities and medical facilities. We operate through two reportable segments, Real Estate Investments and Senior Housing Operating Portfolio (“SHOP”).5 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Interest29¢$57.4M
- Profit71¢$142.2M
Out of $80.1M in revenue.6
Where each dollar of operating cash went, fiscal 2025
- Capital spending63¢$294.0M
- Dividends paid37¢$169.7M
Out of $236.6M of cash from operations. Spending exceeded cash from operations; the rest came from savings or borrowing.6
Financial statements
Every line of the income statement as filed: the last 3 fiscal years, latest first.6
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Rental income | $271.6M | $257.0M | $249.2M |
| Resident fees and services | $80.1M | $54.4M | $48.8M |
| Interest and other income | $24.0M | $23.7M | $21.8M |
| Revenues | $375.6M | $335.2M | $319.8M |
| Depreciation and amortization | $80.9M | $71.4M | $70.0M |
| Interest expense | $57.4M | $59.9M | $58.2M |
| Senior housing operating expenses | $60.9M | $42.3M | $39.6M |
| Legal | $2.7M | $1.1M | $507.0K |
| Franchise, excise and other taxes | $1.1M | $38.0K | $449.0K |
| General and administrative expenses | $26.9M | $20.7M | $19.3M |
| Proxy contest and related | $1.6M | $0 | $0 |
| Taxes and insurance on leased properties | $11.0M | $11.2M | $11.5M |
| Loan and realty (gains) losses, net | -$3.4M | $5.3M | $1.4M |
| Total operating expenses | $239.0M | $211.9M | $200.9M |
| Gains on operations transfers, net | $0 | $0 | $20.0K |
| Gains on sales of real estate properties, net | $456.0K | $6.7M | $14.7M |
| Gains from equity method investment | $3.7M | $402.0K | $555.0K |
| Loss on early retirement of debt | $0 | $0 | -$73.0K |
| Gains on forward equity sales agreements, net | $0 | $6.3M | $0 |
| Other income | $0 | $0 | $202.0K |
| Net income (loss) | $140.8M | $136.6M | $134.4M |
| Add: Net loss attributable to noncontrolling interests | $1.4M | $1.3M | $1.3M |
| Net income attributable to stockholders | $142.2M | $138.0M | $135.7M |
| Less: Net income attributable to unvested restricted stock awards | -$201.0K | -$118.0K | -$57.0K |
| Net income attributable to common stockholders | $142.0M | $137.9M | $135.6M |
| Basic (in shares) | 46.9M shares | 43.8M shares | 43.4M shares |
| Diluted (in shares) | 47.1M shares | 44.1M shares | 43.4M shares |
| Basic (in usd per share) | $3.03 | $3.14 | $3.13 |
| Diluted (in usd per share) | $3.02 | $3.13 | $3.13 |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.6
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Land | $221.7M | $191.9M | ||
| Buildings, building improvements and intangible assets | $3.1B | $2.8B | ||
| Construction in progress | $18.2M | $10.6M | ||
| Total real estate properties | $3.3B | $3.0B | ||
| Less: Accumulated depreciation and amortization | -$822.0M | -$742.3M | ||
| Total real estate properties, net | $2.5B | $2.2B | ||
| Mortgage and other notes receivable, net of credit loss reserves | $203.3M | $268.9M | ||
| Cash and cash equivalents | $19.6M | $24.3M | $22.3M | |
| Straight-line rents receivable | $78.9M | $87.2M | ||
| Assets held for sale, net | $3.6M | $0 | ||
| Total Assets | $2.8B | $2.6B | ||
| Debt, net | $1.2B | $1.1B | ||
| Dividends payable | $44.4M | $41.1M | ||
| Deferred income | $5.0M | $4.3M | ||
| Total Liabilities | $1.3B | $1.2B | ||
| Redeemable noncontrolling interest | $10.2M | $9.8M | $9.7M | |
| Common stock | $483.0K | $457.0K | ||
| Capital in excess of par value | $1.9B | $1.7B | ||
| Retained earnings | $2.7B | $2.6B | ||
| Cumulative dividends | -$3.1B | -$3.0B | ||
| Total National Health Investors, Inc. stockholders equity | $1.5B | $1.4B | ||
| Noncontrolling interests | $8.2M | $8.9M | ||
| Total equity | $1.5B | $1.4B | $1.3B | $1.3B |
| Total liabilities and equity | $2.8B | $2.6B | ||
| Mortgage and other notes receivable, net of reserve | $15.4M | $20.2M | ||
| Common stock, par value (in usd per share) | $0.01 | $0.01 | ||
| Common stock, shares authorized (in shares) | 100.0B shares | 100.0B shares | ||
| Common stock, shares issued (in shares) | 48.3M shares | 45.7M shares | ||
| Common stock, shares outstanding (in shares) | 48.3M shares | 45.7M shares | ||
| Other assets, net | $17.8M | $22.8M | ||
| Accounts payable and accrued liabilities | -$43.7M | -$37.8M |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Land | $221.7M | $191.9M | ||
| Buildings, building improvements and intangible assets | $3.1B | $2.8B | ||
| Construction in progress | $18.2M | $10.6M | ||
| Total real estate properties | $3.3B | $3.0B | ||
| Less: Accumulated depreciation and amortization | -$822.0M | -$742.3M | ||
| Total real estate properties, net | $2.5B | $2.2B | ||
| Mortgage and other notes receivable, net of credit loss reserves | $203.3M | $268.9M | ||
| Cash and cash equivalents | $19.6M | $24.3M | $22.3M | |
| Straight-line rents receivable | $78.9M | $87.2M | ||
| Assets held for sale, net | $3.6M | $0 | ||
| Total Assets | $2.8B | $2.6B | ||
| Debt, net | $1.2B | $1.1B | ||
| Dividends payable | $44.4M | $41.1M | ||
| Deferred income | $5.0M | $4.3M | ||
| Total Liabilities | $1.3B | $1.2B | ||
| Redeemable noncontrolling interest | $10.2M | $9.8M | $9.7M | |
| Common stock | $483.0K | $457.0K | ||
| Capital in excess of par value | $1.9B | $1.7B | ||
| Retained earnings | $2.7B | $2.6B | ||
| Cumulative dividends | -$3.1B | -$3.0B | ||
| Total National Health Investors, Inc. stockholders equity | $1.5B | $1.4B | ||
| Noncontrolling interests | $8.2M | $8.9M | ||
| Total equity | $1.5B | $1.4B | $1.3B | $1.3B |
| Total liabilities and equity | $2.8B | $2.6B | ||
| Mortgage and other notes receivable, net of reserve | $15.4M | $20.2M | ||
| Common stock, par value (in usd per share) | $0.01 | $0.01 | ||
| Common stock, shares authorized (in shares) | 100.0B shares | 100.0B shares | ||
| Common stock, shares issued (in shares) | 48.3M shares | 45.7M shares | ||
| Common stock, shares outstanding (in shares) | 48.3M shares | 45.7M shares | ||
| Other assets, net | $17.8M | $22.8M | ||
| Accounts payable and accrued liabilities | -$43.7M | -$37.8M |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.6
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net income | $140.8M | $136.6M | $134.4M |
| Depreciation and amortization | $80.9M | $71.4M | $70.0M |
| Amortization of lease incentives | $2.9M | $2.9M | $2.5M |
| Amortization of commitment fees and notes receivable discounts | -$920.0K | -$116.0K | -$412.0K |
| Amortization of debt issuance costs and discounts | $3.4M | $3.8M | $2.6M |
| Payments of lease incentives | $0 | $0 | -$10.0M |
| Share-based compensation expense | $5.6M | $4.2M | $4.6M |
| Non-cash rental income related to operations transfers upon early lease terminations | -$1.4M | $0 | $0 |
| Other non-cash rental income | $0 | $0 | -$2.5M |
| Non-cash changes in straight-line rents receivable | $7.3M | -$3.0M | -$7.0M |
| Non-cash interest income on mortgage and other notes receivable | -$1.7M | -$124.0K | -$1.3M |
| Non-cash lease incentives recognized as interest and other income | $0 | -$100.0K | $0 |
| Loan and realty (gains) losses, net | -$3.4M | $5.3M | $1.4M |
| Gains on sales of real estate properties, net | -$456.0K | -$6.7M | -$14.7M |
| Gains from equity method investment | -$3.7M | -$402.0K | -$555.0K |
| Loss on early retirement of debt | $0 | $0 | $73.0K |
| Gains on forward equity sales agreements, net | $0 | -$6.3M | $0 |
| Other assets, net | $57.0K | -$1.9M | -$705.0K |
| Accounts payable and other liabilities | $5.5M | $3.3M | $5.9M |
| Deferred income | $1.7M | -$1.1M | $101.0K |
| Net cash provided by operating activities | $236.6M | $207.8M | $184.4M |
| Acquisitions of real estate properties | -$274.1M | -$138.1M | -$38.1M |
| Investments in existing real estate properties and equipment | -$20.0M | -$19.8M | -$11.5M |
| Proceeds from sales of real estate properties | $0 | $6.2M | $57.0M |
| Investments in mortgage and other notes receivable | -$71.1M | -$60.4M | -$35.6M |
| Payments received on mortgage and other notes receivable | $92.3M | $19.4M | $13.5M |
| Distributions from equity method investment | $3.7M | $402.0K | $3.1M |
| Net cash used in investing activities | -$269.1M | -$192.3M | -$11.6M |
| Proceeds from revolving credit facility | $694.0M | $449.7M | $364.0M |
| Repayments of revolving credit facility | -$821.2M | -$363.5M | -$161.0M |
| Borrowings on bank term loan | $0 | $0 | $200.0M |
| Repayments of bank term loan and private placement notes | -$200.8M | -$75.4M | -$415.4M |
| Proceeds from issuance of senior notes | $346.2M | $0 | $0 |
| Payments of debt issuance costs | -$3.9M | -$3.5M | -$2.7M |
| Proceeds from issuance of common shares, net | $181.5M | $142.4M | $0 |
| Payments of equity issuance costs | -$767.0K | -$930.0K | $0 |
| Capital contributions from noncontrolling interests | $1.7M | $1.2M | $3.0M |
| Distributions paid to noncontrolling interests | -$917.0K | -$1.2M | -$1.3M |
| Dividends paid to stockholders | -$169.7M | -$156.5M | -$156.2M |
| Taxes paid related to net settlement of stock incentive awards | -$456.0K | -$5.8M | $0 |
| Net cash provided by (used in) financing activities | $25.7M | -$13.6M | -$169.7M |
| (Decrease) increase in cash, cash equivalents and restricted cash | -$6.9M | $1.9M | $3.1M |
| Interest paid, net of amounts capitalized | $51.5M | $55.4M | $51.9M |
| Real estate properties acquired to settle mortgage notes receivable | $50.8M | $22.2M | $14.2M |
| Increase in liabilities associated with acquisitions of real estate properties | $778.0K | $0 | $0 |
| Assets received upon early lease terminations | $1.4M | $0 | $0 |
| Right of use assets acquired in exchange for finance lease liabilities | $139.0K | $344.0K | $101.0K |
| Changes in other assets related to sales of real estate properties | $0 | $0 | $325.0K |
| Changes in accounts payable related to real estate property renovations | -$95.0K | -$250.0K | $0 |
| Noncash or Part Noncash Acquisition, Payables Assumed | $0 | $189.0K | $0 |
| Changes in accounts payable related to noncontrolling interest distributions | -$241.0K | $16.0K | $6.0K |
| Increases in notes receivable from sales of real estate properties | $0 | $9.0M | $2.2M |
| Reclassification of prepaid equity issuance costs to capital in excess of par value | $0 | $471.0K | $275.0K |
No quarter-by-quarter statement was filed.
Corporate structure
NATIONAL HEALTH INVESTORS INC sits at the top of its group. 3 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of NATIONAL HEALTH INVESTORS INC
- State Street Corporation Filed SCHEDULE 13G on NATIONAL HEALTH INVESTORS INC, latest Aug 7, 2026
- BlackRock Filed SCHEDULE 13G/A on NATIONAL HEALTH INVESTORS INC, latest Jul 8, 2026 (4 filings since Feb 1, 2022)
- VANGUARD CAPITAL MANAGEMENT LLC Filed SCHEDULE 13G on NATIONAL HEALTH INVESTORS INC, latest Apr 30, 2026
- VANGUARD PORTFOLIO MANAGEMENT LLC Filed SCHEDULE 13G on NATIONAL HEALTH INVESTORS INC, latest Apr 29, 2026
- VANGUARD GROUP INC Filed SCHEDULE 13G/A on NATIONAL HEALTH INVESTORS INC, latest Mar 27, 2026 (4 filings since Feb 10, 2022)
- NATIONAL HEALTH INVESTORS INC Baltimore, Maryland, United States
- NHI REIT of Subsidiary · Alabama, United States
- NHI-Sub REIT of Subsidiary · Colorado, United States
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What NATIONAL HEALTH INVESTORS INC reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Land | $221.7M6 Dec 31, 2025 | $191.9M6 Dec 31, 2024 | +15.5% |
| Construction in progress | $18.2M6 Dec 31, 2025 | $10.6M6 Dec 31, 2024 | +72.4% |
| Property and equipment, before depreciation | $3.3B6 Dec 31, 2025 | $3.0B6 Dec 31, 2024 | +11.6% |
| Accumulated depreciation | $822.0M6 Dec 31, 2025 | $742.3M6 Dec 31, 2024 | +10.7% |
| Property and equipment, net | $2.5B6 Dec 31, 2025 | $2.2B6 Dec 31, 2024 | +11.9% |
| Operating-lease assets (leased space) | $1.5M6 Dec 31, 2025 | $1.5M6 Dec 31, 2024 | 0% |
Real estate and locations
| Item | Latest | A year before | Change |
|---|---|---|---|
| Real estate investments, at cost | $2.7B6 Dec 31, 2025 | $2.6B10 Dec 31, 2024 | +2.6% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $19.6M6 Dec 31, 2025 | $24.3M6 Dec 31, 2024 | −19.2% |
| Loans, net of allowance | $203.3M6 Dec 31, 2025 | $268.9M6 Dec 31, 2024 | −24.4% |
Properties, in its own words
A summary of information related to our owned real estate properties as of and for the year ended December 31, 2025 follows ($ in thousands):
Number of Properties1 · Carrying
The rest of Item 2
Location · SHOs · SNFs · HOSPs · SHOP · NOI · Amount2
Alabama · 2 · 2 · — · — · 3,453 · 24,297
Arizona · — · 1 · — · — · 930 · 7,131
Arkansas · — · — · — · 2 · 2,008 · 53,931
California · 1 · — · — · 5 · 4,672 · 130,774
Colorado · 2 · — · — · — · 2,402 · 28,800
Connecticut · 3 · — · — · — · 13,561 · 139,719
Florida · 2 · 10 · — · 1 · 23,972 · 223,665
Georgia · 3 · — · — · 2 · 7,790 · 108,612
Idaho · 1 · — · — · — · 1,066 · 9,673
Illinois · 13 · — · — · — · 15,449 · 197,528
Indiana · 5 · — · — · 3 · 4,123 · 92,117
Iowa · 7 · — · — · — · 5,585 · 41,384
Kentucky · — · 1 · — · — · 1,568 · 2,143
Louisiana · 2 · — · — · — · 1,183 · 10,241
Maryland · 1 · — · — · 1 · 2,656 · 66,081
Massachusetts · 1 · — · — · — · 3,536 · 52,108
Michigan · 5 · — · — · — · 3,605 · 44,138
Minnesota · 5 · — · — · — · 2,414 · 31,144
Missouri · 1 · 5 · — · — · 3,279 · 27,695
Nebraska · 9 · — · — · — · 7,716 · 92,933
Nevada · 1 · — · — · — · 1,640 · 18,136
New Jersey · 1 · — · — · 1 · 4,058 · 72,894
North Carolina · 16 · — · — · — · 23,742 · 262,408
Ohio · 5 · — · — · 1 · 4,919 · 100,329
Oklahoma · — · — · 1 · 4 · 7,468 · 124,784
Oregon · 3 · 3 · — · 2 · 10,609 · 146,043
Pennsylvania · 2 · — · — · 1 · 1,192 · 81,623
South Carolina · 5 · 4 · — · 2 · 34,748 · 395,552
Tennessee · 3 · 16 · — · — · 19,021 · 50,984
Texas · — · 21 · — · — · 29,221 · 298,599
Virginia · 5 · 1 · — · — · 7,824 · 68,685
Washington · 3 · — · — · 1 · 13,693 · 207,002
Wisconsin · 3 · 1 · — · — · 8,145 · 81,955
Total real estate properties in
segments · 110 · 65 · 1 · 26 · 277,248 · 3,293,108
Corporate · — · 2,632
Other · 2,504 · —
Total real estate properties · 279,752 · 3,295,740
1 The total number of properties, as presented in the table above, excludes our corporate office building and one property in the Real Estate Investments segment that was classified as assets held for sale as of December 31, 2025.
2 The total gross carrying amount, as presented in the table above, excludes $2.6 million related to our corporate office and equipment and $4.8 million related to one property in the Real Estate Investments segment that was classified as assets held for sale as of December 31, 2025.
A summary of information related to our mortgage and other notes receivable investments as of December 31, 2025 and for the year ended December 31, 2025 follows ($ in thousands):
Number of Properties · Interest · Carrying
SHOs · SNFs · HOSPs · Income · Amount
Mortgage notes:
Florida · 2 · — · 1 · 2,703 · 36,942
Illinois · 1 · — · — · 1,360 · 14,907
Indiana · 1 · — · — · 562 · 6,423
Michigan · 2 · — · — · 1,547 · 23,004
South Carolina · 1 · — · — · 195 · 18,750
Texas · 1 · 3 · — · 2,525 · 25,887
Wisconsin · 1 · — · — · 2,513 · 28,414
Total mortgage notes receivable · 9 · 3 · 1 · 11,405 · 154,327
Other notes · 9,727 · 64,366
Mortgage and other note payoffs · 2,684 · —
Other interest income · 150 · —
Total mortgage and other notes receivable · 23,966 · 218,693
The following table provides information on the expirations of our tenant leases based on the maturities included in the most recent lease agreements or extension periods as of December 31, 2025 ($ in thousands):
Percentage of
Number of · Number of · Annualized · Annualized
Year of Maturity · Properties1 · Beds / Units · Gross Rent2 · Gross Rent
2026 · 36 · 4,849 · 39,286 · 14.9
2027 · 4 · 803 · 15,753 · 6.0
2028 · 12 · 591 · 11,948 · 4.5
2029 · 7 · 836 · 12,756 · 4.8
2030 · 1 · 107 · 4,493 · 1.7
2031 · 13 · 2,513 · 57,492 · 21.8
2032 · 2 · 213 · 3,958 · 1.5
2033 · 28 · 1,815 · 28,297 · 10.7
2034 · 16 · 984 · 13,326 · 5.0
Thereafter · 57 · 5,145 · 76,645 · 29.1
Total · 176 · 17,856 · 263,954 · 100.0
1 The total number of properties, as presented in the table above, excludes our corporate office building and one property in the Real Estate Investments segment that was classified as assets held for sale as of December 31, 2025.
2 Annualized gross rent refers to the amount of rental income we would have generated during the year ended December 31, 2025 if all of our tenant leases were in effect for the full calendar year, regardless of the actual commencement dates, maturity dates or renewal periods of the leases.
As of December 31, 2025, we leased 32 SNFs and three ILFs to NHC, a publicly owned company, under a triple-net master lease which expires in December 2026. The master lease includes two five-year extension options in which the annual lease rate resets at the current fair market value as negotiated between the parties. We have engaged Blueprint Healthcare Real Estate Advisors, a national advisory firm focused on senior housing and skilled nursing facilities, to assist with underwriting, due diligence and market analysis with respect to the master lease renewal.
On September 8, 2025, we provided formal written notice to NHC that it is in default of the triple-net master lease as a result of NHC’s failure to remedy its non-compliance with certain non-monetary provisions of the triple-net master lease previously identified by us. NHC had 30 days to cure such default and its failure to do so entitles us to declare an event of default and to pursue any and all remedies available to us under the triple-net master lease. We are currently evaluating potential courses of action.
On October 7, 2025, NHC informed us that it was exercising its option to renew the master lease for one five-year term commencing January 1, 2027. We are currently reviewing the effectiveness and legality of NHC’s notice.
Item 2 of the 10-K filed Feb 26, 2026.5
Leadership
Who has led NATIONAL HEALTH INVESTORS INC, and when. Pick a name to see everywhere that person has worked.
Chief financial officer
Chief operating officer
- Chief executive officerD. Eric Mendelsohn Aug 13, 2015 to now14
- Chief executive officerJames Justin Hutchens Aug 8, 2011 to Apr 2, 201515
- Chief executive officerW. Andrew Adams Sep 1, 2009 to Mar 4, 201116
- PresidentD. Eric Mendelsohn Aug 13, 2015 to now14
- PresidentJames Justin Hutchens Feb 26, 2009 to Apr 2, 201517
- PresidentW. Andrew Adams Feb 1, 2007 to Mar 6, 200918
- Chief financial officerTodd Michael Siefert Jul 2, 2026 to now19
- Chief financial officerJohn L. Spaid Feb 13, 2020 to Jul 2, 202620
- Chief operating officerChristian Ken Maingot Jul 30, 2026 to now21
- Chief operating officerJames Justin Hutchens Feb 26, 2009 to Feb 25, 201117
Board members and other officers (24)
- SVP, Legal AffairsElizabeth Jackson Blankenship Mar 4, 2026 to now22
- SVP/Chief Accounting OfficerDavid L. Travis May 1, 2020 to now23
- Chief Accounting OfficerRonald Reel V. Nov 15, 2019 to Feb 25, 202024
- Exec. VP of FinanceJohn L. Spaid Mar 8, 2016 to Feb 25, 201925
- EVP - Corporate FinanceD. Eric Mendelsohn Jan 26, 2015 to Jun 11, 201526
- EVP - InvestmentsKevin Carlton Pascoe Jan 26, 2015 to now27
- Chief Credit OfficerKristin Sallee Gaines Mar 3, 2010 to now28
- Senior V.P. & TreasurerCharlotte A. Swafford Jan 9, 2007 to Jan 9, 200729
- Senior V.P. & ControllerDonald K. Daniel Jan 9, 2007 to Jan 9, 200730
- Chief Accounting OfficerRoger R. Hopkins Jan 9, 2007 to Feb 25, 201931
- Senior Vice President, FinanceKenneth D. Denbesten Mar 13, 2006 to Apr 24, 200832
- SecretaryRichard F. Laroche Jr. May 4, 2006 to May 4, 200633
- Board memberLilly Donohue Feb 27, 2026 to now34
- Board memberCandice W. Todd Jan 3, 2025 to now35
- Board memberRobert Chapin Apr 22, 2025 to now36
- Board memberD. Eric Mendelsohn May 8, 2023 to now37
- Board memberTracy M. J. Colden Jun 1, 2022 to now38
- Board memberCharlotte A. Swafford May 8, 2020 to now39
- Board memberRobert G. Adams May 8, 2020 to now40
- Board memberJames R. Jobe May 8, 2013 to now41
- Board memberJames Justin Hutchens Aug 8, 2011 to Apr 2, 201515
- Board memberW. Andrew Adams Feb 1, 2007 to Oct 3, 202418
- Board memberRobert T. Webb Jan 31, 2006 to Sep 5, 202442
- Board memberRichard F. Laroche Jr. May 4, 2006 to Mar 12, 200833
Subsidiaries and ownership
Subsidiaries (Exhibit 21)
- NHI REIT of Alabama, L.P. 100% DE4
- NHI-REIT of California, LP 100% DE4
- NHI-Sub REIT of Colorado, LLC 100% DE4
- NHI/REIT of Florida, L.P. 100% DE4
The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.
Timeline
- Aug 27, 20268-K Executive or director change43
- Aug 10, 20268-K Results of operations44
- Aug 10, 20268-K Regulation FD disclosure45
- Aug 10, 20268-K Regulation FD disclosure46
- Jul 27, 20268-K Executive or director change47
- Jul 1, 20268-K Executive or director change48
- Jul 1, 20268-K Ended a material agreement; Completed an acquisition or sale49
- Jun 1, 20268-K Other events50
- May 29, 20268-K Shareholder vote51
- May 4, 20268-K Results of operations52
- May 4, 20268-K Regulation FD disclosure53
- May 4, 20268-K Regulation FD disclosure54
- Aug 13, 2015New chief executive D. Eric Mendelsohn becomes CEO14
- Aug 8, 2011New chief executive James Justin Hutchens becomes CEO15
- Sep 1, 2009New chief executive W. Andrew Adams becomes CEO16
- Jul 24, 1991Founded NATIONAL HEALTH INVESTORS INC is founded2
Calendar
Coming up
- Nov 9, 2026 · After the closeReports results for the quarter ending Sep/2026 A year earlier it reported $1.32 a share, on Nov 6, 2025.55
When it reported results
- Aug 10, 2026Reported quarterly or annual results44
- May 4, 2026Reported quarterly or annual results52
- Feb 26, 2026Reported quarterly or annual results56
- Nov 6, 2025Reported quarterly or annual results57
- Aug 6, 2025Reported quarterly or annual results58
- May 5, 2025Reported quarterly or annual results59
- Feb 25, 2025Reported quarterly or annual results60
- Nov 5, 2024Reported quarterly or annual results61
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
310 filings to the SEC since October 2021: 7 annual reports, 15 quarterly reports, 97 major events, 131 insider forms, 11 large holders, 49 other. The latest 20:
- Aug 27, 20268-K EDGAR
- Aug 17, 2026144 EDGAR
- Aug 10, 20268-K EDGAR
- Aug 10, 20268-K EDGAR
- Aug 10, 20268-K EDGAR
- Aug 10, 202610-Q EDGAR
- Aug 7, 2026SCHEDULE 13G EDGAR
- Jul 30, 20264 PRIMARY DOCUMENT EDGAR
- Jul 30, 20263 PRIMARY DOCUMENT EDGAR
- Jul 27, 20268-K EDGAR
- Jul 8, 2026SCHEDULE 13G/A EDGAR
- Jul 2, 20263 PRIMARY DOCUMENT EDGAR
- Jul 1, 20268-K EDGAR
- Jul 1, 20268-K EDGAR
- Jun 15, 20264 PRIMARY DOCUMENT EDGAR
- Jun 9, 20264 PRIMARY DOCUMENT EDGAR
- Jun 5, 20264 PRIMARY DOCUMENT EDGAR
- Jun 1, 20268-K EDGAR
- May 29, 20268-K EDGAR
- May 7, 20264 PRIMARY DOCUMENT EDGAR
The 310 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
10 open-market trades by officers, directors and large owners since October 2021: 10 buys and 0 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | MCCABE ROBERT A JRDirector | Buy | 890 | $71.65 | $63.8K | Form 4 |
| Jun 5, 2026 | Mendelsohn D. EricCEO and President | Buy | 1,500 | $68.84 | $103.3K | Form 4 |
| May 31, 2024 | MCCABE ROBERT A JRDirector | Buy | 437 | $65.83 | $28.8K | Form 4 |
| Feb 27, 2024 | SWAFFORD CHARLOTTE ADirector | Buy | 10,000 | $58.69 | $586.9K | Form 4 |
| Aug 30, 2023 | Jobe James RDirector | Buy | 1,000 | $51.40 | $51.4K | Form 4 |
| Dec 14, 2022 | ADAMS ROBERT GDirector | Buy | 1,000 | $56.60 | $56.6K | Form 4 |
| Aug 15, 2022 | ADAMS ROBERT GDirector | Buy | 1,500 | $65.93 | $98.9K | Form 4 |
| Dec 30, 2021 | ADAMS ROBERT GDirector | Buy | 2,000 | $57.25 | $114.5K | Form 4 |
| Dec 1, 2021 | WEBB ROBERT TDirector | Buy | 2,000 | $51.60 | $103.2K | Form 4 |
| Nov 29, 2021 | WEBB ROBERT TDirector | Buy | 1,000 | $52.86 | $52.9K | Form 4 |
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- State Street CorporationSCHEDULE 13G, 1 filing Aug 7, 202662
- BlackRockSCHEDULE 13G/A, 4 filings Feb 1, 2022 to Jul 8, 202663
- VANGUARD CAPITAL MANAGEMENT LLCSCHEDULE 13G, 1 filing Apr 30, 202664
- VANGUARD PORTFOLIO MANAGEMENT LLCSCHEDULE 13G, 1 filing Apr 29, 202665
- VANGUARD GROUP INCSCHEDULE 13G/A, 4 filings Feb 10, 2022 to Mar 27, 202666
Executive pay
What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.
| Year | Executive | Age | Salary | Total pay |
|---|---|---|---|---|
| 2025 | D. Eric MendelsohnCEO and President | $700.0K | $3.7M67 | |
| 2025 | John L. SpaidChief Financial Officer | $520.0K | $2.2M67 | |
| 2025 | Kevin C. PascoeChief Investment Officer | $400.0K | $2.0M67 | |
| 2025 | David L. TravisChief Accounting Officer | $330.0K | $1.4M67 | |
| 2025 | Kristin S. GainesChief Transaction Officer | $225.0K | $1.3M67 | |
| 2024 | D. Eric MendelsohnCEO and President | $525.0K | $2.2M67 | |
| 2024 | John L. SpaidChief Financial Officer | $420.0K | $1.3M67 | |
| 2024 | Kevin C. PascoeChief Investment Officer | $249.5K | $1.1M67 | |
| 2024 | Kristin S. GainesChief Transaction Officer | $216.3K | $971.9K67 | |
| 2024 | David L. TravisChief Accounting Officer | $315.0K | $970.6K67 | |
| 2023 | D. Eric MendelsohnCEO and President | $500.0K | $2.1M67 | |
| 2023 | John L. SpaidChief Financial Officer | $400.0K | $1.3M67 | |
| 2023 | Kevin C. PascoeChief Investment Officer | $242.3K | $1.2M67 | |
| 2023 | Kristin S. GainesChief Transaction Officer | $206.0K | $1.1M67 | |
| 2023 | David L. TravisChief Accounting Officer | $300.0K | $1.0M67 |
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| BlackRock, Inc. | 8,733,237 | $666.0M | 0.0% | +3,926,380 |
| Vanguard Portfolio Management LLC | 4,630,646 | $353.1M | 0.0% | +488,430 |
| State Street Corp | 2,735,937 | $211.1M | 0.0% | +761,547 |
| Vanguard Capital Management LLC | 2,099,145 | $160.1M | 0.0% | +14,525 |
| Principal Financial Group Inc | 1,977,094 | $150.8M | 0.1% | +276,186 |
| Bank of New York Mellon Corp | 1,606,463 | $122.5M | 0.0% | +1,091,732 |
| Geode Capital Management, LLC | 1,402,775 | $107.0M | 0.0% | +91,535 |
| Bank Of America Corp /de/ | 1,019,379 | $77.7M | 0.0% | +26,577 |
| Charles Schwab Investment Management Inc | 880,321 | $67.1M | 0.0% | +54,330 |
| Nomura Asset Management International Inc. | 870,365 | $66.4M | 0.1% | −26,937 |
| Dimensional Fund Advisors LP | 675,739 | $51.5M | 0.0% | −10,510 |
| Norges Bank | 672,355 | $51.3M | 0.0% | New |
| Northern Trust Corp | 608,688 | $46.4M | 0.0% | +45,841 |
| Morgan Stanley | 444,043 | $33.9M | 0.0% | +64,157 |
| Jpmorgan Chase & Co | 415,413 | $32.4M | 0.0% | −571,179 |
| UBS Group AG | 396,229 | $30.2M | 0.0% | +268,595 |
| Two Sigma Investments, LP | 335,445 | $25.6M | 0.0% | −84,629 |
| Vanguard Fiduciary Trust Co | 321,018 | $24.5M | 0.0% | +9,275 |
| Legal & General Group Plc | 285,144 | $21.7M | 0.0% | +53,401 |
| Bowen Hanes & Co Inc | 260,000 | $21.0M | 0.5% | No change |
| Sound Income Strategies, LLC | 270,252 | $20.6M | 0.9% | +12,540 |
| Prudential Financial Inc | 257,108 | $19.6M | 0.0% | −880,075 |
| Algert Global LLC | 248,865 | $19.0M | 0.2% | +103,285 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 242,935 | $18.5M | 0.0% | +6,627 |
| Goldman Sachs Group Inc | 235,078 | $17.9M | 0.0% | +18,350 |
13F reports cover disclosed long positions in U.S. stocks only.
Members of Congress who traded it
12 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.
| Date | Member | Trade | Amount | Vs S&P since | Filing |
|---|---|---|---|---|---|
| Jul 10, 2026 | Gilbert Ray Cisneros, Jr.Democratic, House | Buy | $1,001 - $15,000 | −15.1% | Report |
| Jan 15, 2026 | Gilbert Ray Cisneros, Jr.Democratic, House | Buy | $1,001 - $15,000 | −29.8% | Report |
| Sep 1, 2022 | Virginia FoxxRepublican, House | Sale | $50,001 - $100,000 | +92.8% | Report |
| Jun 28, 2022 | Virginia FoxxRepublican, House | Buy | $15,001 - $50,000 | −96.3% | Report |
| Jan 28, 2022 | Virginia FoxxRepublican, House | Sale | $50,001 - $100,000 | +60.7% | Report |
| Nov 8, 2021 | Virginia FoxxRepublican, House | Buy | $1,001 - $15,000 | −43.9% | Report |
| Aug 9, 2021 | Virginia FoxxRepublican, House | Buy | $1,001 - $15,000 | −74.2% | Report |
| Aug 6, 2021 | Virginia FoxxRepublican, House | Buy | $1,001 - $15,000 | −75.9% | Report |
| May 27, 2021 | Virginia FoxxRepublican, House | Buy | $15,001 - $50,000 | −83.9% | Report |
| May 12, 2021 | Virginia FoxxRepublican, House | Buy | $15,001 - $50,000 | −90.3% | Report |
| Apr 19, 2021 | Virginia FoxxRepublican, House | Buy | $50,001 - $100,000 | −96.3% | Report |
| Mar 31, 2020 | Gilbert Ray Cisneros, Jr.Democratic, House | Buy | $1,001 - $15,000 | −166.8% | Report |
Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).
SEC filer profile
How NATIONAL HEALTH INVESTORS INC is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARNATIONAL HEALTH INVESTORS INC1
- CIK0000877860
- Employer ID (EIN)62-14709565
- Filer statusLarge accelerated filer not an emerging growth company; not a smaller reporting company; not a shell company5
- Incorporated inMaryland5
- Fiscal year endsDecember 311
- Industry code (SIC)6798 Real Estate Investment Trusts1
- SEC reviewing officeOffice of Real Estate & Construction, Division of Corporation Finance1
- Business address222 Robert Rose Drive, Murfreesboro, TN 371291
- Phone61589091001
- Shares outstanding49,110,434 as of Aug 3, 202612
- Public float$2.9B as of Jun 30, 20255
- AuditorBDO USA, P.C., Nashville, Tennessee PCAOB ID 243; it also attests to the company’s internal control over financial reporting5
- On EDGAR sinceFeb 1, 19941
- Filings1,554 in all: 8-K (528), 4 (519), 10-Q (91), SC 13G/A (65), 5 (51), DEF 14A (28), 10-K (24), SC 13G (23)1
All 48 form types
3 (22), UPLOAD (21), 424B5 (19), 4/A (17), CORRESP (16), 8-K/A (15), 10-K/A (13), DEFA14A (12), DFAN14A (9), ARS (8), S-3ASR (7), 10-K405 (6), S-8 (6), 10-Q/A (5), PRE 14A (4), SC 13D/A (4), FWP (3), POSASR (3), PX14A6G (3), SC 13D (3), SCHEDULE 13G (3), 25 (2), 424B2 (2), 5/A (2), DEFC14A (2), POS AM (2), PREC14A (2), SCHEDULE 13G/A (2), 144 (1), 25-NSE (1), 3/A (1), 8-A12B (1), 8-A12G (1), DEF 14C (1), NT 10-K (1), NT 10-Q (1), PRRN14A (1), RW (1), S-3 (1), S-8 POS (1)
- Latest filingsAnnual report (10-K) Feb 26, 2026
Quarterly report (10-Q) Aug 10, 2026
Proxy statement (DEF 14A) Apr 3, 2026
Latest 8-K (8-K) Aug 27, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Common Stock, $0.01 par value | NHI | New York Stock Exchange |
From the cover page of the 10-K filed Feb 26, 2026 (Section 12(b) of the Exchange Act).5
Risk factors and legal proceedings
The risks NATIONAL HEALTH INVESTORS INC names in Item 1A of its 10-K filed Feb 26, 2026: 43 risks under these headings, as written.5
- Risks Related to Our Business and Operations
- We depend on the operating success of our tenants, managers and borrowers and if their financial condition or business prospects deteriorate, our business, financial condition and results of operations could be adversely affected.
- We are exposed to the risk that our tenants, managers and borrowers may become subject to bankruptcy or insolvency proceedings.
- A small number of tenants in our portfolio account for a significant percentage of the rental income we expect to generate from our portfolio, and the failure of any of these tenants to meet their obligations to us could materially and adversely affect our business, financial condition and results of operations and our ability to make distributions to our stockholders.
- We have rights to terminate our management agreements with managers, in whole or with respect to specific properties under certain circumstances, and we may be unable to replace managers if our management agreements are terminated or not renewed.
- Actual or perceived risks associated with pandemics, epidemics or outbreaks have had, and may in the future, have a material adverse effect on our operators’ business and results of operations.
- A member of our Board of Directors is also the chairman of the board of directors of NHC, and his interests may differ from those of our stockholders.
- We are exposed to risks related to government regulations and payors, principally Medicare and Medicaid, and the effect of changes to laws, regulations and reimbursement rates on the businesses of our tenants, managers and borrowers.
- We are exposed to the risk that the cash flows of our tenants, managers and borrowers may be adversely affected by increased liability claims and liability insurance costs.
- Significant legal or regulatory proceedings could adversely affect the liquidity, financial condition and results of operations of our tenants, managers and borrowers.
- We are exposed to the risk that we may not be fully indemnified by our tenants, managers and borrowers against future litigation.
- We depend on the success of property development and construction activities, which may fail to achieve the operating results we expect.
The other 32 risks
- We are exposed to the risk that the illiquidity of real estate investments could impede our ability to respond to adverse changes in the performance of our properties.
- Our investments are concentrated in healthcare properties.
- We are subject to risks related to our investment with Life Care Services for Timber Ridge, an entrance fee CCRC, associated with Type A benefits offered to the residents of the CCRC and related accounting requirements.
- Risks related to our joint venture investments could adversely affect our financial condition and results of operations.
- Inflation and increased interest rates may adversely affect our business, financial condition and results of operations.
- Adverse developments affecting the financial services industry, including events or concerns involving liquidity, defaults, or non-performance by financial institutions, could adversely affect our business, financial condition, results of operations or our prospects.
- Adverse geopolitical developments could have a material adverse impact on our business.
- We are exposed to operational risks with respect to our SHOP structured communities.
- A cybersecurity incident or other form of data breach involving Company information could cause a loss of confidential consumer and other personal information, give rise to remediation and other expenses, expose us to liability under privacy and security and consumer protection laws, subject us to federal and state governmental inquiries, damage our reputation, and otherwise be disruptive to our business.
- We are exposed to risks related to environmental laws and the costs associated with liabilities related to hazardous substances.
- We are subject to risks of damage from catastrophic weather and other natural or man-made disasters and the physical effects of climate change.
- We depend on the success of our future acquisitions and investments.
- We depend on our ability to reinvest cash in real estate investments in a timely manner and on acceptable terms.
- Competition for acquisitions may result in increased prices for properties.
- We depend on our ability to retain our management team and other personnel and attract suitable replacements should any such personnel leave.
- We are exposed to the risk that our assets may be subject to impairment charges.
- Stockholder activism efforts could cause us to incur substantial costs, divert management’s attention and have an adverse effect on our business.
- Our ability to raise capital through equity sales is dependent, in part, on the market price of our common stock, and our failure to meet market expectations with respect to our business, or other factors we do not control, could negatively impact such market price and availability of equity capital.
- The U.S. federal income tax treatment of the cash that we might receive from cash settlement of the forward equity sales agreements is unclear and could jeopardize our ability to meet the REIT qualification requirements.
- Our use of artificial intelligence could expose us to various risks.
- Risks Related to Our Debt
- We may need to refinance existing debt or incur additional debt in the future, which may not be available on terms acceptable to us.
- We have covenants related to our indebtedness which impose certain operational limitations and a breach of those covenants could materially adversely affect our financial condition and results of operations.
- Downgrades in our credit ratings could have a material adverse effect on our cost and availability of capital.
- We rely on external sources of capital to fund future capital needs, and if we encounter difficulty in obtaining such capital, we may not be able to make future investments necessary to grow our business or meet maturing commitments.
- We depend on revenues derived mainly from fixed rate investments in real estate assets, while a portion of our debt used to finance those investments bears interest at variable rates, which subjects us to interest rate risk.
- Risks Related to Our Status as a REIT
- We depend on the ability to continue to qualify for taxation as a REIT for U.S. federal income tax purposes.
- There are no assurances of our ability to pay dividends in the future.
- Complying with the REIT requirements may cause us to forego otherwise attractive acquisition opportunities or liquidate otherwise attractive investments, which could materially hinder our performance.
- Our ownership of and relationship with any TRS that we have formed or will form will be limited, and a failure to comply with the limits would jeopardize our REIT status and may result in the application of a 100% excise tax.
- Legislative, regulatory, or administrative tax changes could adversely affect us or our security holders.
- Risks Related to Our Organizational Structure
- We have ownership limits in our charter with respect to our common stock and other classes of capital stock which may delay, defer or prevent a transaction or a change of control that might involve a premium price for our common stock or might otherwise be in the best interests of our stockholders.
- We are subject to certain provisions of Maryland law and our charter and bylaws that could hinder, delay or prevent a change in control transaction, even if the transaction involves a premium price for our common stock or our stockholders believe such transaction to be otherwise in their best interests.
Legal proceedings
From time to time, we are a party to various lawsuits, investigations, claims and other legal and regulatory proceedings arising in connection with our business. Such claims may include, among other things, professional and general liability claims, as well as regulatory proceedings related to our SHOP segment. Further, from time to time, we are a party to certain legal proceedings for which third parties, such as our tenants, managers and borrowers, are contractually obligated to indemnify us from and against various claims, litigation and liabilities arising in connection with their respective businesses. Management believes that the ultimate resolution of all such pending proceedings will have no material adverse effect on our financial condition, results of operations or cash flows.
The opening of Item 3, Legal Proceedings.5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17SEC EDGARJames Justin Hutchens, President
- 18SEC EDGARW. Andrew Adams, President
- 19
- 20
- 21
- 22
- 23
- 24
- 25SEC EDGARJohn L. Spaid, Exec. VP of Finance
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33SEC EDGARRichard F. Laroche Jr., Secretary
- 34SEC EDGARLilly Donohue, Board member
- 35SEC EDGARCandice W. Todd, Board member
- 36SEC EDGARRobert Chapin, Board member
- 37SEC EDGARD. Eric Mendelsohn, Board member
- 38SEC EDGARTracy M. J. Colden, Board member
- 39SEC EDGARCharlotte A. Swafford, Board member
- 40SEC EDGARRobert G. Adams, Board member
- 41SEC EDGARJames R. Jobe, Board member
- 42SEC EDGARRobert T. Webb, Board member
- 43SEC EDGARExecutive or director change
- 44SEC EDGARResults of operations
- 45SEC EDGARRegulation FD disclosure
- 46SEC EDGARRegulation FD disclosure
- 47SEC EDGARExecutive or director change
- 48SEC EDGARExecutive or director change
- 49
- 50SEC EDGAROther events
- 51SEC EDGARShareholder vote
- 52SEC EDGARResults of operations
- 53SEC EDGARRegulation FD disclosure
- 54SEC EDGARRegulation FD disclosure
- 55NasdaqNasdaq calendar
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67